Warning: This data is provided for information purpose only. You should not start or stop any medication without consulting your care giver.
Use the Health Monitor application at http://www.healthsupportsystems.com to search for a drug by brand, generic or symptom
ADVAIR HFA
Active Ingredients
FLUTICASONE PROPIONATE,SALMETEROL XINAFOATE
Inctive Ingredients
propellant HFA-134a
Usage
ADVAIR HFA is indicated for the long-term, twice-daily maintenance treatment of asthma in patients 12 years of age and older.
Long-acting beta2-adrenergic agonists, such as salmeterol, one of the active ingredients in ADVAIR HFA, may increase the risk of asthma-related death (see WARNINGS). Therefore, when treating patients with asthma, physicians should only prescribe ADVAIR HFA for patients not adequately controlled on other asthma-controller medications (e.g., low- to medium-dose inhaled corticosteroids) or whose disease severity clearly warrants initiation of treatment with 2 maintenance therapies. ADVAIR HFA is not indicated in patients whose asthma can be successfully managed by inhaled corticosteroids along with occasional use of inhaled, short-acting beta2-agonists.
ADVAIR HFA is NOT indicated for the relief of acute bronchospasm.